Latest Breaking News On - Daniela camardo - Page 1 : comparemela.com

Athersys end 2023 on a down note | Crain s Cleveland Business

Athersys end 2023 on a down note | Crain s Cleveland Business
crainscleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainscleveland.com Daily Mail and Mail on Sunday newspapers.

Maia hansenDaniela camardoAthersys incExchange commission

Athersys ends 2023 on a down note | Crain s Cleveland Business

Athersys ends 2023 on a down note | Crain s Cleveland Business
crainscleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainscleveland.com Daily Mail and Mail on Sunday newspapers.

Maia hansenDaniela camardoExchange commissionAthersys inc

Athersys (ATHX) – Research Analysts Weekly Ratings Updates

Athersys (NASDAQ: ATHX) recently received a number of ratings updates from brokerages and research firms: 6/8/2022 – Athersys was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of […]

United statesDaniela camardoVirtu financialZacks investment researchJanus henderson groupClaraphi advisory networkAdvisor groupAmerica coTobias financial advisors incAthersys incFast trackBreakthrough therapyGet ratingHenderson groupAdvisory networkTobias financial advisors

Athersys (NASDAQ:ATHX) Upgraded by Zacks Investment Research to Hold

Athersys (NASDAQ:ATHX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs […]

United statesDaniela camardoGeode capital managementZacks investment researchVahanian associates financial planning incAthersys company profile get ratingBlackrock incVanguard group incAthersys incGet ratingFast trackBreakthrough therapyAssociates financial planningStreet corpCapital managementCompany profile

Athersys (NASDAQ:ATHX) Raised to Hold at Zacks Investment Research

Athersys (NASDAQ:ATHX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs […]

United statesDaniela camardoSecurities exchange commissionZacks investment researchVahanian associates financial planning incAthersys company profile get ratingRenaissance technologiesAmerica corpVanguard group incAthersys incGet ratingFast trackBreakthrough therapyExchange commissionAssociates financial planningCompany profile